Showing 11,881 - 11,900 results of 226,405 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((greater decrease) OR (larger decrease)) ))', query time: 1.63s Refine Results
  1. 11881
  2. 11882

    S4 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  3. 11883

    S1 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  4. 11884

    S5 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  5. 11885

    S3 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  6. 11886

    S6 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  7. 11887

    Input parameters for the base-case analysis. by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  8. 11888

    S2 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  9. 11889

    S1 Data - by R. J. S. D. Heine (17889199)

    Published 2024
    “…</p><p>Methods</p><p>The model was used to calculate cumulative yearly prices, cumulative prices per indication, and non-cumulative indication-based prices using inputs such as research and development (R&D) costs, manufacturing costs, eligible patient population, and a profit margin. A deterministic stepwise analysis and scenario analysis were conducted to examine how sensitive the estimated price is to the different input assumptions.…”
  10. 11890
  11. 11891
  12. 11892
  13. 11893
  14. 11894
  15. 11895
  16. 11896
  17. 11897
  18. 11898
  19. 11899
  20. 11900